当院での急性冠症候群患者における脂質コントロールの現況

In Japan atherosclerosis society guideline, it is recommended for secondary prevention of acute coronary syndrome to manage lipid. In particular, hyper-LDLemia is known to develop and promote atherosclerosis, and lowering the LDL-C level leads to suppression of recurrence of atherosclerosis. We investigated the profile of lipid control in patients who succeeded in percutaneous coronary intervention for acute coronary syndrome（ACS）at our hospital, and examined by high risk patients（chronic kidney disease, diabetes, obesity）. The achievement rate of LDL-C <１００ at discharge was６２％ of all cases, and the achievement rate of LDL-C <７０was only１６％. In particular, only１２％ of obese patients achieved LDL-C <７０. In recent years, it has been shown that additional administration of ezetimibe or PCSK９ inhibitor to statins further lowers LDL-C and significantly reduces the risk of developing cardiovascular disease. We should recognize that some ACS patients have not reached their goals and actively treat them for secondary prevention.

著者英表記誤記あり　(誤)Ayummi Okada →(正)Ayumi Okada